AVITA Medical, Inc. (RCEL): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2019-06-30 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$20.84M

Year ended 2025-12-31

$20.15M

Trailing 12 months to 2026-06-30

+14.6%

3-year compound annual growth

2018-06-30 R&D Expense (USD) 2025-12-31

Period ended	R&D Expense	Change YoY	Source filing
2025-12-31	$20.84M	+2.4%	2026-02-12, From 2025-01-01
2024-12-31	$20.36M	-2.2%	2026-02-12, From 2024-01-01
2023-12-31	$20.82M	+50.3%	2025-02-13, From 2023-01-01
2022-12-31	$13.86M	n/a	2024-02-22, From 2022-01-01
No annual figure between 2021-06-30 and 2022-12-31.
2021-06-30	$14.82M	+61.7%	2023-02-23, From 2020-07-01
2020-06-30	$9.16M	+14.5%	2021-08-26, From 2019-07-01
2019-06-30	$8.00M	n/c	2021-08-26, From 2018-07-01
2018-06-30	$6.26M	n/a	2020-08-27, From 2017-07-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	R&D Expense	Change YoY
AVITA Medical, Inc. (RCEL)	2025-12-31	$20.84M	+2.4%
Sight Sciences, Inc. (SGHT)	2025-12-31	$14.61M	-18.8%
PRO DEX Inc (PDEX)	2026-06-30	$3.35M	-8.0%
TELA Bio, Inc. (TELA)	2025-12-31	$9.22M	+4.6%
Meihua International Medical Technologies Co., Ltd. (MHUAF)	2025-12-31	$2.38M	-31.0%
Iradimed Corp (IRMD)	2025-12-31	$2.98M	+5.0%
Delcath Systems, Inc. (DCTH)	2025-12-31	$29.25M	+110.8%
LENSAR, Inc. (LNSR)	2025-12-31	$5.62M	+5.5%
Pulmonx Corp (LUNG)	2025-12-31	$19.49M	+10.9%

Compare RCEL, SGHT, PDEX, TELA side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗